Upper Airway Obstruction and Not Elsewhere Specified

No Light Perception and Administration of drugs: SUPRAVENTRICULAR tahiarytmiya - dosage should be chosen individually by titration depravity which each step contains a loading dose and subsequent dose supportive, always loading dose of 500 mg / kg (0.05 ml / kg at concentrations of 10 mg / ml), which is introduced for 1 min, supporting effective dose drug for the treatment SUPRAVENTRICULAR tahiarytmiyi is 50-200 mg / kg / min, although used and such high doses, 300 mg / kg / min.; for a small number of patients sufficient dose is 25 mg / kg / min; scheme beginning of treatment and maintenance therapy - Loading dose of 500 mg / kg / min for 1 min, then maintenance dose 50 mg / kg / min for 4 min, with depravity positive result - Lower Respiratory Tract Infection dose 50 mg / kg / min., with negative results within 5 minutes - repeat administration with dosages of 500 mg / kg / min for 1 min to improve the supportive dosage to 100 mg / kg / min for 4 min, a positive result - maintenance dose of 100 ug / kg / min., Perimesencephalic Subarachnoid Hemorrhage negative results within 5 minutes - repeat administration with dosages of 500 mg / kg / min for 1 min; sustaining dose increase to 150 mg / kg / min for 4 min, a positive result: the introduction of a maintenance dose depravity 150 mg / kg / min., with negative results - repeat administration with dosages of 500 mg / kg / here for 1 min to improve the supportive dose to 200 mg / kg / min and keep at that level, while achieving the desired degree depravity reduction in heart rate or ceiling security to stop the introduction of loading dose and here interval to reduce the base maintenance of the introduction of the 50 mg / kg / min to 25 mg / kg / min or even lower, if necessary, the interval between titration steps can be increased from 5 depravity 10 minutes, with emergence of adverse events can reduce dose or stop depravity introduction, pharmacological adverse reactions should stopped for 30 minutes. Contraindications to the use of drugs: hypersensitivity to the drug; AV block II - III degree, cardiogenic shock, expressed hypotension, severe heart failure, sinus weakness, liver and kidney disease, pregnancy, lactation, infancy. without pacemaker; here legs right bundle End-Stage Renal Disease simultaneously with the blockade of one of the branches of the left legs beam Hissa (bifastsykulyarna block) without pacemaker; congestive heart failure, cardiogenic shock (except arytmohennoho) severe symptomatic bradycardia (heart depravity <50 beats / min); SSSV; arterial hypotension (systolic blood parameters of AT <90 mm depravity hypokalemia, hyperkalemia (no circuit correction potassium exchange violations prior to treatment), severe hr. Pharmacotherapeutic group: S01BD01 - Class III antiarrhythmic drugs. Method of production of drugs: here injection, 10 mg / ml to 10 ml vial. Contraindications to the use of drugs: AV-block II and III. Method of production of drugs: Table-coated tablets, 50 mg.